Biosimilars Market Research Reports & Industry Analysis
The worldwide prescription generic drug market has stood the test of time and has endured numerous growing pains. However, it has evolved into a formidable and important participant in the complex world of health care. Generic drugs continue to represent one of the greatest values in healthcare and are of great importance in the area of biopharmaceuticals as well because these products are among the most expensive treatments currently on the market.
Generic drug manufacturers are poised for strong growth in the future because the patent protection for a host of major biopharmaceuticals will expire and new legislative reforms in the generic drug approval process may facilitate bringing products to market. While there are many issues to address, the outlook for the promotion of biosimilars is favorable in the next five years.
Biosimilars Industry Research & Market Reports
-
2024 United States Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Brazil Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
2024 United Kingdom Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published ... Read More
-
2024 Asia-Pacific Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
2024 Japan Biosimilars Forecast (2025-2030 Outlook)-Market Opportunities Report
... market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service sales are published historically ... Read More
-
Global Biologics and Biosimilars Competitive Landscape Professional Research Report 2024
... used for the treatment of various diseases, including cancer, autoimmune disorders, and genetic diseases. Biologics are often highly complex and require specialized manufacturing techniques to ensure their safety, efficacy, and consistency. Biosimilars, on the other ... Read More
-
Biologics Contract Development and Manufacturing Organization (CDMO) Market Forecasts to 2030 - Global Analysis By Product (Biosimilars, Biologics and Other Products), Service (Contract Manufacturing Organization (CMO) and Contract Research Organization (CRO)), Type, End User and By Geography
... By Geography According to Stratistics MRC, the Global Biologics Contract Development and Manufacturing Organization (CDMO) Market is accounted for $14.54 billion in 2024 and is expected to reach $33.45 billion by 2030 growing at a ... Read More
-
Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2024-2030
... 5.05 billion in 2023 and expected to reach USD 5.80 billion in 2024, at a CAGR 14.51% to reach USD 13.04 billion by 2030. The recombinant proteins are created by inserting a modified gene into ... Read More
-
Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Global Forecast 2024-2030
... 46.76 billion in 2024, at a CAGR 7.63% to reach USD 73.03 billion by 2030. The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... USD 4812.9 million in 2023 and is forecast to a readjusted size of USD 5470.7 million by 2030 with a CAGR of 1.8% during review period. A biosimilar medicine is a medicinal product of biological ... Read More
-
Biosimilars and Follow-On Biologics Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Demand of Drugs For Treating ... Read More
-
Global Interchangeable Biosimilars Market Growth 2024-2030
... have minor differences in composition, quality, purity and biological activity compared to the reference biological drug, but these differences do not affect their efficacy or safety. Interchangeable biosimilars are generally considered to be effective alternatives ... Read More
-
Global Pharmaceutical Continuous Manufacturing
... adoption in specific areas such as small molecule oral solid dosage forms and large molecules, the market has consistently demonstrated robust year-on-year growth. Projections indicate that the global pharmaceutical continuous manufacturing market will experience a ... Read More
-
2024 Global Forecast for Biosimilar Contract Manufacturing Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Biosimilar Monoclonal Antibodies Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
PEGylated Proteins Market
... the competitive environment for PEGylated proteins, including coverage of the pipeline activities adopted by players in this market, and it includes market projections for 2028. Also included are company profiles of key players featuring detailed ... Read More
-
Global Erythropoietin Drugs Databank Market Report
... 2029. Cancer segment is expected to be the highest contributor to this market, with $3,381.2 Million in 2020, and is anticipated to reach $6,689.5 Million by 2029, registering a CAGR of 7.92%. Renal Diseases segment ... Read More
-
Biologics and Biosimilars Industry Research Report 2024
... proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Opportunities and Forecast to 2030
... biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. ... Read More
-
Global Biologics and Biosimilars Market Analysis and Forecast 2024-2030
... proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. A biosimilar in ... Read More
-
Global Biologics and Biosimilars Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but ... Read More
-
Global Biologics and Biosimilars Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting significant ... Read More
-
Human Insulin Market Size, Trends, Analysis, and Outlook By Product (Drugs, Delivery Devices), By Drug (Insulin Analogs and Biosimilars, Human Insulin Biologics), By Brand (Insulin Analogs and Biosimilars, Human Insulin Biologics, Insulatard, Mixtard), By Delivery Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032
... Device (Pens, Pen Needles, Syringes), by Country, Segment, and Companies, 2024-2032 The global Human Insulin market size is poised to register 4.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in ... Read More
-
Biosimilars Market Size, Trends, Analysis, and Outlook By Product (Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins), By Application (Oncology, Blood Disorders, Growth Hormonal Deficiency, Rheumatoid Arthritis, Chronic & Autoimmune Disorders, Others), by Country, Segment, and Companies, 2024-2032
... 2024-2032 The global Biosimilars market size is poised to register 12.5% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Biosimilars market across ... Read More
Research Assistance
